Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements are listed here. Any amendments to an announcement will be listed in the funding opportunity announcement. For contracts, see NIAID Contract Solicitations. For other funding opportunity resources, see Find a Foundation or Other Funding Source.

Showing results filtered by:
Title Activity Code Posting Date Expiration Date
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)- PA-18-858 R21 July 18, 2018 September 8, 2021
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)- PA-18-859 R01 July 18, 2018 September 8, 2021
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)- RFA-AI-18-036 UM1 July 9, 2018 January 4, 2019
Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)- RFA-AI-18-037 R01 July 3, 2018 December 6, 2018
Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed)- RFA-AI-18-025 R21 June 28, 2018 November 16, 2018
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)- RFA-AI-18-022 U01 June 28, 2018 October 10, 2019
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)- PAR-18-840 D43 June 26, 2018 July 26, 2019
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-18-837 Supp June 20, 2018 September 5, 2021
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)- RFA-AI-18-026 R01 June 19, 2018 December 14, 2018
Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)- RFA-AI-18-023 R01 June 14, 2018 October 5, 2018
Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)- RFA-AI-18-006 R61/R33 June 11, 2018 December 1, 2018
Rare Diseases Clinical Research Consortia (RDCRC) for Rare Diseases Clinical Research Network (U54 Clinical Trials Optional)- RFA-TR-18-020 U54 June 8, 2018 October 10, 2018
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)- PAR-18-822 R01 June 7, 2018 September 5, 2020
Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)- PA-18-817 Supp June 5, 2018 April 16, 2020
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)- PAR-18-781 R21 May 11, 2018 September 10, 2020
Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)- RFA-AI-18-015 U01 April 25, 2018 September 28, 2018
Targeted In Vivo Delivery of Gene Therapeutics for HIV Cure (R01 Clinical Trial Not Allowed)- RFA-AI-18-016 R01 April 20, 2018 August 1, 2018
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)- PAR-18-764 R01 April 20, 2018 May 8, 2021
Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed)- RFA-AI-18-017 R01 April 11, 2018 July 28, 2018
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)- PA-18-753 R01 April 11, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed)- PA-18-754 R21 April 11, 2018 May 8, 2021
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)- PAR-18-740 Si2/R00 April 3, 2018 September 1, 2018
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-Associated Variants (R01 Clinical Trial Not Allowed)- RFA-DK-18-005 R01 April 3, 2018 December 7, 2018
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)- PA-18-728 R21 March 28, 2018 January 8, 2021
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)- PA-18-729 R01 March 28, 2018 January 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) - PA-18-724 R21 March 28, 2018 May 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)- PA-18-725 R01 March 28, 2018 May 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)- PA-18-722 R01 March 28, 2018 May 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)- PA-18-723 R21 March 28, 2018 May 8, 2021
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-18-712 R01 March 15, 2018 May 8, 2021
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)- PAR-18-679 K99/R00 February 23, 2018 May 8, 2020
Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-18-673 F30 February 20, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-18-668 F30 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)- PA-18-670 F32 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)- PA-18-671 F31 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)- PA-18-666 F31 February 15, 2018 January 8, 2021
Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)- RFA-DK-17-020 R01 February 14, 2018 December 7, 2018
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)- PA-18-651 R01 February 12, 2018 January 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)- PA-18-652 R21 February 12, 2018 January 8, 2021
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)- PA-18-648 R13 February 9, 2018 January 8, 2021
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)- PAR-18-632 U44 February 6, 2018 January 14, 2021
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)- PAR-18-633 U01 February 6, 2018 January 14, 2021
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-18-630 R01 February 5, 2018 December 7, 2019
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)- PA-18-589 January 26, 2018 January 26, 2021
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)- PA-18-590 January 26, 2018 January 26, 2021
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)- PA-18-591 Supp January 25, 2018 January 26, 2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)- PA-18-586 Supp January 25, 2018 September 8, 2021
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )- PA-18-592 Supp January 25, 2018 September 8, 2021
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-18-574 R43/R44 January 16, 2018 April 6, 2019
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-18-575 R41/R42 January 16, 2018 April 6, 2019
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)- PA-18-525 R43/R44 December 19, 2017 January 6, 2021
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)- PA-18-504 R15 December 13, 2017 January 8, 2021
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-18-484 R01 December 6, 2017 January 8, 2021
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-18-488 R03 December 6, 2017 January 8, 2021
NIH Exploratory/Developmental Research Grant Program ( Parent R21 Clinical Trial Not Allowed)- PA-18-489 R21 December 6, 2017 January 8, 2021
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)- PA-18-398 K99/R00 November 29, 2017 January 8, 2021
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - No Independent Clinical Trials)- PA-18-394 K24 November 22, 2017 January 8, 2021
Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)- PA-18-396 K25 November 22, 2017 January 8, 2021
Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials)- PA-18-373 K08 November 21, 2017 January 8, 2021
Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trials Not Allowed)- PA-18-375 K23 November 21, 2017 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)- PA-18-403 T32 November 21, 2017 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)- PA-18-404 T35 November 21, 2017 January 8, 2021
Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not Allowed)- PA-18-369 K01 November 20, 2017 January 8, 2021
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Trophoblast Differentiation and Function (R21 Clinical Trial Optional)- PA-18-047 R21 November 15, 2017 January 8, 2020
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)- PA-18-048 R21 November 15, 2017 January 8, 2020
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)- PAR-18-206 R01 November 7, 2017 May 8, 2019
The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) - PA-18-037 R01 November 6, 2017 September 8, 2018
The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional)- PA-18-040 R21 November 6, 2017 September 8, 2018
The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) - PA-18-054 R03 November 6, 2017 September 8, 2018
The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional)- PA-18-210 R15 November 6, 2017 September 8, 2018
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-18-007 R01 November 3, 2017 May 8, 2019
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-18-017 R21 November 3, 2017 May 8, 2019
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)- PA-18-344 R21 November 3, 2017 January 8, 2021
NIH Research Project Grant (Parent R01 Clinical Trial Required)- PA-18-345 R01 November 3, 2017 January 8, 2021
Global Infectious Disease Research Administration Development Award for Low- and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)- PAR-18-335 G11 October 31, 2017 August 1, 2020
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)- PAR-18-333 R01 October 25, 2017 December 6, 2019
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
Research on Transgender Health (R21) - PA-17-477 R21 September 8, 2017 January 8, 2021
Research on Transgender Health (R01)- PA-17-478 R01 September 8, 2017 January 8, 2021
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
Stimulating Access to Research in Residency (StARR) (R38)- RFA-HL-18-023 R38 August 23, 2017 January 25, 2020
NIAID Research Education Program (R25)- PAR-17-455 R25 August 11, 2017 December 6, 2019
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)- PA-17-445 R03 August 1, 2017 September 8, 2020
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)- PA-17-446 R21 August 1, 2017 September 8, 2020
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03) - PAR-17-439 R03 July 28, 2017 September 8, 2020
Assay development and screening for discovery of chemical probes or therapeutic agents (R01)- PAR-17-438 R01 July 27, 2017 September 8, 2020
Small Grants on Primary Immunodeficiency Diseases (R03)- PAR-17-332 R03 July 21, 2017 July 17, 2019
Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)- PAR-17-333 R21 July 21, 2017 July 17, 2019
NIAID Physician-Scientist Pathway to Independence Award (K99/R00)- PAR-17-329 K99/R00 July 20, 2017 May 8, 2020
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)- PA-17-281 R21 May 12, 2017 May 8, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)- PA-17-278 R21 May 12, 2017 May 8, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)- PA-17-279 R01 May 12, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)- PA-17-280 R01 May 12, 2017 May 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020
Modeling of Infectious Disease Agent Study Research Projects (R01)- PAR-17-267 R01 May 5, 2017 May 8, 2019
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Centers for AIDS Research (P30)- PAR-17-237 P30 March 30, 2017 August 18, 2019
Developmental Centers for AIDS Research (P30)- PAR-17-238 P30 March 30, 2017 August 18, 2019
International Research in Infectious Diseases, including AIDS (R01) - PAR-17-142 R01 January 27, 2017 August 23, 2019
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
Phylodynamic Tracking of HIV Transmission (R01)- PAR-17-048 R01 November 4, 2016 March 16, 2019
Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)- PAR-17-035 R43/R44 October 27, 2016 September 6, 2019
Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)- PAR-17-036 R41/R42 October 27, 2016 September 6, 2019
Trophoblast Differentiation and Function (R01)- PA-16-445 R01 September 23, 2016 January 8, 2020
Support of Competitive Research (SCORE) Pilot Project Award- PAR-16-438 SC2 September 21, 2016 September 8, 2019
Support of Competitive Research (SCORE) Research Advancement Award - PAR-16-439 SC1 September 21, 2016 September 8, 2019
NIAID Career Transition Award- PAR-16-434 K22 September 16, 2016 September 8, 2019
NIAID Investigator-Initiated Program Project Applications- PAR-16-413 P01 August 18, 2016 September 8, 2019
NIAID Resource-Related Research Projects- PAR-16-412 R24 August 18, 2016 September 8, 2019
Serious Adverse Drug Reaction Research (R21)- PAR-16-274 R21 May 19, 2016 September 8, 2019
Serious Adverse Drug Reaction Research (R01)- PAR-16-275 R01 May 19, 2016 September 8, 2019
NIAID Clinical Trial Planning Grant- PAR-16-272 R34 May 18, 2016 May 14, 2019
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP)- PAR-16-262 R01 May 17, 2016 January 5, 2019
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design- PAR-16-254 R01 May 11, 2016 January 12, 2019
Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort- PAR-16-253 UH2 May 10, 2016 October 5, 2018
Dissemination and Implementation Research in Health (R01)- PAR-16-238 R01 May 10, 2016 May 8, 2019
Dissemination and Implementation Research in Health (R21)- PAR-16-236 R21 May 10, 2016 May 8, 2019
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R01)- PA-16-243 R01 May 9, 2016 September 8, 2019
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R21)- PA-16-244 R21 May 9, 2016 September 8, 2019
The Use of mRNA for an HIV Envelope Vaccine (R43/R44)- PA-16-207 R43/R44 April 19, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R41/R42)- PA-16-208 R41/R42 April 19, 2016 April 6, 2019
Tools for Cell Line Identification- PA-16-186 R43/R44 April 15, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)- PA-16-182 R41/R42 April 12, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)- PA-16-184 R43/R44 April 12, 2016 April 6, 2019
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)- PA-16-163 R03 April 4, 2016 May 8, 2019
Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir- PAR-16-115 R01 February 25, 2016 January 10, 2019
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)- PAR-16-093 R01 February 9, 2016 May 8, 2019
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)- PAR-16-094 R21 February 9, 2016 May 8, 2019
Research to Advance Vaccine Safety (R21)- PA-15-313 R21 July 28, 2015 September 8, 2018
Research to Advance Vaccine Safety (R01)- PA-15-312 R01 July 28, 2015 September 8, 2018